Literature DB >> 20483316

Mechanisms underlying the antifibrillatory action of hyperkalemia in Guinea pig hearts.

Sandeep V Pandit1, Mark Warren, Sergey Mironov, Elena G Tolkacheva, Jérôme Kalifa, Omer Berenfeld, José Jalife.   

Abstract

Hyperkalemia increases the organization of ventricular fibrillation (VF) and may also terminate it by mechanisms that remain unclear. We previously showed that the left-to-right heterogeneity of excitation and wave fragmentation present in fibrillating guinea pig hearts is mediated by chamber-specific outward conductance differences in the inward rectifier potassium current (I(K1)). We hypothesized that hyperkalemia-mediated depolarization of the reversal potential of I(K1) (E(K1)) would reduce excitability and thereby reduce VF excitation frequencies and left-to-right heterogeneity. We induced VF in Langendroff-perfused guinea pig hearts and increased the extracellular K(+) concentration ([K(+)](o)) from control (4 mM) to 7 mM (n = 5) or 10 mM (n = 7). Optical mapping enabled spatial characterization of excitation dominant frequencies (DFs) and wavebreaks, and identification of sustained rotors (>4 cycles). During VF, hyperkalemia reduced the maximum DF of the left ventricle (LV) from 31.5 +/- 4.7 Hz (control) to 23.0 +/- 4.7 Hz (7.0 mM) or 19.5 +/- 3.6 Hz (10.0 mM; p < 0.006), the left-to-right DF gradient from 14.7 +/- 3.6 Hz (control) to 4.4 +/- 1.3 Hz (7 mM) and 3.2 +/- 1.4 Hz (10 mM), the number of DF domains, and the incidence of wavebreak in the LV and interventricular regions. During 10 mM [K(+)](o), the rotation period and core area of sustained rotors in the LV increased, and VF often terminated. Two-dimensional computer simulations mimicking experimental VF predicted that clamping E(K1) to normokalemic values during simulated hyperkalemia prevented all of the hyperkalemia-induced VF changes. During hyperkalemia, despite the shortening of the action potential duration, depolarization of E(K1) increased refractoriness, leading to a slowing of VF, which effectively superseded the influence of I(K1) conductance differences on VF organization. This reduced the left-to-right excitation gradients and heterogeneous wavebreak formation. Overall, these results provide, to our knowledge, the first direct mechanistic insight into the organization and/or termination of VF by hyperkalemia. Copyright 2010 Biophysical Society. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20483316      PMCID: PMC2872203          DOI: 10.1016/j.bpj.2010.02.011

Source DB:  PubMed          Journal:  Biophys J        ISSN: 0006-3495            Impact factor:   4.033


  22 in total

1.  Unique Kir2.x properties determine regional and species differences in the cardiac inward rectifier K+ current.

Authors:  Amit S Dhamoon; Sandeep V Pandit; Farzad Sarmast; Keely R Parisian; Prabal Guha; You Li; Suveer Bagwe; Steven M Taffet; Justus M B Anumonwo
Journal:  Circ Res       Date:  2004-04-15       Impact factor: 17.367

Review 2.  Electrolyte abnormalities underlying lethal and ventricular arrhythmias.

Authors:  L S Gettes
Journal:  Circulation       Date:  1992-01       Impact factor: 29.690

Review 3.  Electrophysiological mechanisms of ventricular arrhythmias resulting from myocardial ischemia and infarction.

Authors:  M J Janse; A L Wit
Journal:  Physiol Rev       Date:  1989-10       Impact factor: 37.312

4.  Effects of pacing on stationary reentrant activity. Theoretical and experimental study.

Authors:  J M Davidenko; R Salomonsz; A M Pertsov; W T Baxter; J Jalife
Journal:  Circ Res       Date:  1995-12       Impact factor: 17.367

5.  Spatially distributed dominant excitation frequencies reveal hidden organization in atrial fibrillation in the Langendorff-perfused sheep heart.

Authors:  O Berenfeld; R Mandapati; S Dixit; A C Skanes; J Chen; M Mansour; J Jalife
Journal:  J Cardiovasc Electrophysiol       Date:  2000-08

6.  Effects of [K(+)](o) on electrical restitution and activation dynamics during ventricular fibrillation.

Authors:  M L Koller; M L Riccio; R F Gilmour
Journal:  Am J Physiol Heart Circ Physiol       Date:  2000-12       Impact factor: 4.733

Review 7.  Antiarrhythmic mechanisms during exercise.

Authors:  D J Paterson
Journal:  J Appl Physiol (1985)       Date:  1996-06

8.  Sudden death associated with short-QT syndrome linked to mutations in HERG.

Authors:  Ramon Brugada; Kui Hong; Robert Dumaine; Jonathan Cordeiro; Fiorenzo Gaita; Martin Borggrefe; Teresa M Menendez; Josep Brugada; Guido D Pollevick; Christian Wolpert; Elena Burashnikov; Kiyotaka Matsuo; Yue Sheng Wu; Alejandra Guerchicoff; Francesca Bianchi; Carla Giustetto; Rainer Schimpf; Pedro Brugada; Charles Antzelevitch
Journal:  Circulation       Date:  2003-12-15       Impact factor: 29.690

9.  Blockade of the inward rectifying potassium current terminates ventricular fibrillation in the guinea pig heart.

Authors:  Mark Warren; Prabal K Guha; Omer Berenfeld; Alexey Zaitsev; Justus M B Anumonwo; Amit S Dhamoon; Suveer Bagwe; Steven M Taffet; José Jalife
Journal:  J Cardiovasc Electrophysiol       Date:  2003-06

10.  Electrophysiological mechanisms for the initiation and maintenance of ventricular fibrillation in nonischemic rabbit hearts.

Authors:  Y Watanabe; H Toda; H Uchida
Journal:  Heart Vessels Suppl       Date:  1987
View more
  12 in total

1.  Targeting atrioventricular differences in ion channel properties for terminating acute atrial fibrillation in pigs.

Authors:  Sandeep V Pandit; Sharon Zlochiver; David Filgueiras-Rama; Sergey Mironov; Masatoshi Yamazaki; Steven R Ennis; Sami F Noujaim; Antony J Workman; Omer Berenfeld; Jerome Kalifa; José Jalife
Journal:  Cardiovasc Res       Date:  2010-11-13       Impact factor: 10.787

2.  Self-terminated long-lasting ventricular fibrillation: What is the mechanism?

Authors:  Shozo Konishi; Hitoshi Minamiguchi; Masaharu Masuda; Takashi Ashihara; Yuji Okuyama; Tomohito Ohtani; Yasushi Sakata
Journal:  J Cardiol Cases       Date:  2014-08-06

3.  Modeling and simulation of cardiac electric activity in a human cardiac tissue with multiple ischemic zones.

Authors:  Meena Pargaei; B V Rathish Kumar; Luca F Pavarino
Journal:  J Math Biol       Date:  2019-07-27       Impact factor: 2.259

4.  Mechanisms for the Termination of Atrial Fibrillation by Localized Ablation: Computational and Clinical Studies.

Authors:  Wouter-Jan Rappel; Junaid A B Zaman; Sanjiv M Narayan
Journal:  Circ Arrhythm Electrophysiol       Date:  2015-09-10

Review 5.  Ionic mechanisms of arrhythmogenesis.

Authors:  Justus M Anumonwo; Sandeep V Pandit
Journal:  Trends Cardiovasc Med       Date:  2015-01-16       Impact factor: 6.677

6.  Mechanisms by Which Ranolazine Terminates Paroxysmal but Not Persistent Atrial Fibrillation.

Authors:  Rafael J Ramirez; Yoshio Takemoto; Raphaël P Martins; David Filgueiras-Rama; Steven R Ennis; Sergey Mironov; Sandesh Bhushal; Makarand Deo; Sridharan Rajamani; Omer Berenfeld; Luiz Belardinelli; José Jalife; Sandeep V Pandit
Journal:  Circ Arrhythm Electrophysiol       Date:  2019-10-09

Review 7.  Rotors and the dynamics of cardiac fibrillation.

Authors:  Sandeep V Pandit; José Jalife
Journal:  Circ Res       Date:  2013-03-01       Impact factor: 17.367

8.  Does the combination of hyperkalemia and KATP activation determine excitation rate gradient and electrical failure in the globally ischemic fibrillating heart?

Authors:  Tyson G Taylor; Paul W Venable; Alicja Booth; Vivek Garg; Junko Shibayama; Alexey V Zaitsev
Journal:  Am J Physiol Heart Circ Physiol       Date:  2013-07-19       Impact factor: 4.733

9.  Potassium-induced conversion of ventricular fibrillation after aortic declamping.

Authors:  Sven M Almdahl; Jens Damstuen; Magne Eide; Per Mølstad; Per Halvorsen; Terje Veel
Journal:  Interact Cardiovasc Thorac Surg       Date:  2012-10-31

10.  The transient outward potassium current plays a key role in spiral wave breakup in ventricular tissue.

Authors:  Julian Landaw; Xiaoping Yuan; Peng-Sheng Chen; Zhilin Qu
Journal:  Am J Physiol Heart Circ Physiol       Date:  2021-01-01       Impact factor: 4.733

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.